IMS Health: Pharma Should Make Better Use of Social Media To Engage Patients and Improve the Use of Medicines
13/12/2014Standard Social Media Practices Are Risky For Big Pharma – Law360
13/12/2014J&J, Glaxo are tops in social media, but smaller drugmakers rate highly, too
It’s no revelation that pharma is behind the curve when it comes to social media. Consider yourselves fortunate, then, that the IMS Institute for Healthcare Informatics chose to delve into the subject.
Source: www.fiercepharma.com
